Top Markets
Coin of the day
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Peringkat dalam Saham #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Harga Saham
$12.94
Terakhir disinkronkan: 2026-08-28
Kapitalisasi Pasar
$1.10B
Perubahan (1 hari)
-0.16%
Perubahan (1 tahun)
-51.50%
Negara
US
Perdagangan Kolon TissueGene, Inc. (950160)

Kategori

Harga 950160 dengan kapitalisasi pasar B
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
950160
$12.94
Kapitalisasi pasar dari Kolon TissueGene, Inc.(950160)
Kapitalisasi Pasar: $1.10B
Per August 2026, Kolon TissueGene, Inc. memiliki kapitalisasi pasar sebesar $1.10B. Ini menjadikan Kolon TissueGene, Inc. sebagai perusahaan 9085th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Kolon TissueGene, Inc. dari 2017 hingga 2026
950160 dibandingkan dengan 5 teratas stocks paling populer
Harga 950160 Aset B Pasar B Hasil
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$62,120.76 $1.10B
$5.264T +480,047.64%
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$55,481.41 $1.10B
$4.701T +428,730.41%
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$49,296.35 $1.10B
$4.177T +380,924.40%
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$45,050.50 $1.10B
$3.817T +348,107.10%
Kolon TissueGene, Inc. Kolon TissueGene, Inc.
$33,826.65 $1.10B
$2.866T +261,355.06%